The Landscape of Lyme Borreliosis Surveillance in Europe
- PMID: 37071402
- PMCID: PMC10122255
- DOI: 10.1089/vbz.2022.0067
The Landscape of Lyme Borreliosis Surveillance in Europe
Abstract
Purpose: Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe and the incidence of LB is increasing owing to an expansion in tick habitats. However, LB surveillance is quite heterogeneous across the continent, and for those countries with publicly available data, it is difficult to understand the differences in incidence between countries. The objective of our study was to summarize the publicly available data from surveillance for LB in the form of surveillance reports and/or dashboards and to compare the information available for various countries. Methods: We identified publicly available LB data (online dashboards and surveillance reports) in the European Union, European Economic Area, the United Kingdom, Russia, and Switzerland. Results: Of the 36 countries studied, 28 had LB surveillance in place; 23 had surveillance reports, and 10 had dashboards. The dashboards, in general, had more granular data compared with the surveillance reports, but the reports covered longer time periods. LB annual cases, incidence, age, and sex-stratified LB data; manifestations; and regional data were available for most of the countries. LB case definitions varied significantly among the countries. Conclusion: The study highlights large differences in LB surveillance systems, including representativeness, case definitions, type of data available that might inhibit comparison of data between countries and accurate determination of burden of disease, and risk groups within countries. Standardization of case definitions across countries would be a useful first step enabling comparisons between countries and contribute to recognizing the true burden of LB in Europe.
Keywords: Europe; Lyme borreliosis; dashboards; surveillance; vaccine.
Conflict of interest statement
A.V., A.P., E.B., B.D.G., and J.H.S. are employees of Pfizer and may hold stock or stock options. A.N., J.S., and M.R.-M. are employees of P95, which was contracted by Pfizer to conduct the research described in the article.
Figures

Similar articles
-
Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005-2020).Vector Borne Zoonotic Dis. 2023 Apr;23(4):156-171. doi: 10.1089/vbz.2022.0071. Vector Borne Zoonotic Dis. 2023. PMID: 37071405 Free PMC article.
-
Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005-2020).Vector Borne Zoonotic Dis. 2023 Apr;23(4):172-194. doi: 10.1089/vbz.2022.0070. Vector Borne Zoonotic Dis. 2023. PMID: 37071407 Free PMC article.
-
Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area.Euro Surveill. 2017 Jul 6;22(27):30569. doi: 10.2807/1560-7917.ES.2017.22.27.30569. Euro Surveill. 2017. PMID: 28703098 Free PMC article.
-
Incidence of Lyme Borreliosis in Finland: Exploring Observed Trends Over Time Using Public Surveillance Data, 2015-2020.Vector Borne Zoonotic Dis. 2023 Apr;23(4):256-264. doi: 10.1089/vbz.2022.0047. Epub 2023 Jan 27. Vector Borne Zoonotic Dis. 2023. PMID: 37071400 Free PMC article.
-
Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012.Ticks Tick Borne Dis. 2014 Apr;5(3):219-24. doi: 10.1016/j.ttbdis.2013.10.010. Epub 2014 Mar 19. Ticks Tick Borne Dis. 2014. PMID: 24656810
Cited by
-
Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005-2020).Vector Borne Zoonotic Dis. 2023 Apr;23(4):156-171. doi: 10.1089/vbz.2022.0071. Vector Borne Zoonotic Dis. 2023. PMID: 37071405 Free PMC article.
-
Factors influencing Lyme borreliosis risk perception in Europe: a cross-sectional multi-country survey study.BMC Public Health. 2025 Aug 1;25(1):2603. doi: 10.1186/s12889-025-23722-z. BMC Public Health. 2025. PMID: 40751188 Free PMC article.
-
The Role of Environmental Factors in Lyme Disease Transmission in the European Union: A Systematic Review.Trop Med Infect Dis. 2024 May 15;9(5):113. doi: 10.3390/tropicalmed9050113. Trop Med Infect Dis. 2024. PMID: 38787046 Free PMC article. Review.
-
Twenty Years of Lyme Borreliosis in the Netherlands: Temporal Trends in Seroprevalence and Risk Factors.Microorganisms. 2024 Oct 30;12(11):2185. doi: 10.3390/microorganisms12112185. Microorganisms. 2024. PMID: 39597574 Free PMC article.
-
Exploratory actor mapping of social interactions within tick risk surveillance networks in France.Curr Res Parasitol Vector Borne Dis. 2024 Oct 10;6:100222. doi: 10.1016/j.crpvbd.2024.100222. eCollection 2024. Curr Res Parasitol Vector Borne Dis. 2024. PMID: 39524489 Free PMC article.
References
-
- Allen HB, Vin H, Warner C, et al. . Lyme disease: Beyond erythema migrans. J Clin Exp Dermatol Res 2016;7:330.
-
- Centers for Disease Control and Prevention. Updated Guidelines for Evaluating Public Health Surveillance Systems: Recommendations from the Guidelines Working Group. 2001. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm [Last accessed: August 10, 2021].
-
- Duclos P. National Immunization Technical Advisory Groups (NITAGs): Guidance for their establishment and strengthening. Vaccine 2010;28:A18–A25. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical